[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.48.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editor's Correspondence
September 13, 2010

Conflicting Evidence Surrounding the Clopidogrel and Proton Pump Inhibitor Drug Interaction

Author Affiliations

Author Affiliations: Pharmacy Department, St Paul's Hospital, Vancouver, British Columbia, Canada.

Arch Intern Med. 2010;170(16):1507-1508. doi:10.1001/archinternmed.2010.299

In the April 26, 2010, issue of the Archives, Stockl et al1 reported a clinically significant drug interaction between clopidogrel and proton pump inhibitors (PPIs) based on their retrospective cohort study of health insurance claims. Their study concluded that concomitant clopidogrel and PPI use was associated with higher rates of hospitalization for myocardial infarction (MI) or coronary stent placement. However, there is more recent evidence that contradicts their conclusion and was not discussed in their article.

First Page Preview View Large
First page PDF preview
First page PDF preview
×